168 related articles for article (PubMed ID: 16107121)
1. Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction: a brief case series.
Albrecht CA; Giesler GM; Kar B; Hariharan R; Delgado RM
Tex Heart Inst J; 2005; 32(2):220-3. PubMed ID: 16107121
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J
J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113
[TBL] [Abstract][Full Text] [Related]
3. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure.
Hatzizacharias A; Makris T; Krespi P; Triposkiadis F; Voyatzi P; Dalianis N; Kyriakidis M
Am Heart J; 1999 Aug; 138(2 Pt 1):241-6. PubMed ID: 10426834
[TBL] [Abstract][Full Text] [Related]
4. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
Cuffe MS; Califf RM; Adams KF; Benza R; Bourge R; Colucci WS; Massie BM; O'Connor CM; Pina I; Quigg R; Silver MA; Gheorghiade M;
JAMA; 2002 Mar; 287(12):1541-7. PubMed ID: 11911756
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
Cusick DA; Pfeifer PB; Quigg RJ
Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
[TBL] [Abstract][Full Text] [Related]
7. [Heart function and clinical observations of patients with severe congestive heart failure treated with milrinone].
Lu G; Zheng Z; Zhang L
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):27-9. PubMed ID: 10322703
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.
Schubert S; Peters B; Abdul-Khaliq H; Nagdyman N; Lange PE; Ewert P
Catheter Cardiovasc Interv; 2005 Mar; 64(3):333-7. PubMed ID: 15736252
[TBL] [Abstract][Full Text] [Related]
11. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
Curley M; Liebers J; Maynard R
J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
[TBL] [Abstract][Full Text] [Related]
12. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
13. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
Felker GM; Benza RL; Chandler AB; Leimberger JD; Cuffe MS; Califf RM; Gheorghiade M; O'Connor CM;
J Am Coll Cardiol; 2003 Mar; 41(6):997-1003. PubMed ID: 12651048
[TBL] [Abstract][Full Text] [Related]
14. Intravenous milrinone in treatment of advanced congestive heart failure.
Zewail AM; Nawar M; Vrtovec B; Eastwood C; Kar MN; Delgado RM
Tex Heart Inst J; 2003; 30(2):109-13. PubMed ID: 12809251
[TBL] [Abstract][Full Text] [Related]
15. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
Varriale P; Ramaprasad S
Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
[TBL] [Abstract][Full Text] [Related]
16. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
17. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
18. Long-term support with milrinone prior to cardiac transplantation in a neonate with left ventricular noncompaction cardiomyopathy.
McMahon CJ; Murchan H; Prendiville T; Burch M
Pediatr Cardiol; 2007; 28(4):317-8. PubMed ID: 17551772
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
[TBL] [Abstract][Full Text] [Related]
20. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.
St-Pierre P; Deschamps A; Cartier R; Basmadjian AJ; Denault AY
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):723-9. PubMed ID: 23623891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
